A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma

Cancer

Volumn 86, Issue 8, 1999, Pages 1480-1487

  Lebeau, Bernard ^a   Urban, Thierry ^a   Bréchot, Jeanne Marie ^b   Paillotin, Dominique ^c   Vincent, Jean ^d   Leclerc, Pascal ^e   Meekel, Paul ^f   L'Her, Pierre ^g   Lebas, François Xavier ^h   Chastang, Claude ⁱ  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔTEL DIEU   (France)

^c Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^d Centre hospitalier général   (France)

^e Centre Hospitaler Regional et Univ   (France)

^f CENTRE HOSPITALIER DE TROYES   (France)

^g PERCY MILITARY HOSPITAL   (France)

^h Service de Pneumologie   (France)

ⁱ SAINT LOUIS HOSPITAL   (France)

Author keywords

Chemotherapy; Cisplatin; Lung carcinoma; Pulmonary fibrosis; Radiotherapy; Randomized study; Small cell lung carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRRADIATION; LUNG FIBROSIS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; REMISSION; THORAX RADIOGRAPHY; THORAX WALL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; PULMONARY FIBROSIS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VINDESINE;

EID: 0033570251     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1480::AID-CNCR14>3.0.CO;2-O     Document Type: Article

References (16)

1. Byhardt RW, Cox JD. Is thoracic radiation therapy necessary in any or all patients with small cell carcinoma of the lung? Yes. Cancer Treat Rep 1983;67:209-15.
2. Cohen MH. Is thoracic radiation therapy necessary for patients with limited stage small cell lung cancer? No. Cancer Treat Rep 1983;67:217-21.
3. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, et al. A metaanalysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992;327:1618-24.
4. Lebeau B, Chastang C, Brechot JM, Capron F, for the Petites Cellules Group. A randomized trial of delayed thoracic radiotherapy in complete responder patients with small cell lung cancer. Chest 1993;104:726-33.
5. Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336-44.
6. Takada M, Fukuoka M, Furuse K, Ariyoshi Y, Ikegami H, Kurita Y, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer: preliminary results of the Japan clinical oncology group [abstract]. Proc Am Soc Clin Oncol 1996;15:372.
7. Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-8.
8. Arriagada R, Le Chevalier T, Baldeyrou P, Pico JL, Ruffle P, Martin M, et al. Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. Int J Radiat Oncol Biol Phys 1985;11:1461-7.
9. Lebeau B, Chastang C, Allard P, Migueres J, Boita F, Fichet D, and the "Petites Cellules" group. Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. Eur Respir J 1992;5:286-90.
10. George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. J Chron Dis 1994;27:15-24.
11. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, et al. Interruptions of high-dose radiation therapy decrease long term survival of favorable patients with unresectable non small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 1993;27:493-8.
13. Johnson DH, Kim K, Sause W, Komaki R, Wagner H, Aisner S, et al. Cisplatin and etoposide + thoracic radiotherapy administered once or twice daily in limited stage small cell lung cancer: final report of intergroup trial 0096 [abstract]. Proc Am Soc Clin Oncol 1996;15:374.
14. Le Chevalier T, Arriagada R, Thomas F, Baldeyrou P, Ruffle P, de Cremoux H, et al. Experience of the Institut Gustave Roussy in alternating radiotherapy schedules as induction treatment in limited small cell lung cancer. In: Arriagada R, editor. Treatment modalities in lung cancer. Basel: Karger. Antibiot Chemother 1988,41:190-3.
15. Arriagada R, Auperin A, Pignon JP, Gregor A, Stephens R, Kristjansen PEG, et al. Prophylactic cranial irradiation overview (PCIO) in patients with small cell lung cancer (SCLC) in complete remission (CR) [abstract]. Proc Am Soc Clin Oncol 1998;17:457a.
16. Gregor A, Drings P, Burghouts J, Postmus PE, Morgan D, Sahmoud T, et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997;15:2840-9.